Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2020: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
We specifically addressed myeloid-derived suppressor cells (MDSCs) and T-cell immunity, which are thought to play an important role in the formation of the tumor microenvironment. We investigated their role in tumor immunomodulation both in the tumor itself and in the tumor surrounding environment when combined with cryoablation and ICIs. Our findings suggest that the combination of cryoablation and ICI might have synergetic anti-tumor effects, which could be evaluated by monitoring of MDSCs and T-cell immunity.
|